+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Similarities and distinctions between murine natural killer cells and lymphokine-activated killer cells



Similarities and distinctions between murine natural killer cells and lymphokine-activated killer cells



Cellular Immunology 100(2): 563-569



Pretreatment of mice with rabbit anti-asialo GM1 removes both natural killer (NK) effector cells and NK cells responsive to interleukin 2 (IL-2). Spleen cells from these mice do possess normal lymphokine-activated killer (LAK) activity. Young mice (less than 3 weeks of age) do not have NK activity and do not possess IL-2-inducible NK effector cells. Similarly to anti-asialo GM1-treated mice, LAK cells can be generated from these mice. While these experiments indicate clear distinctions between a certain level of NK and LAK precursors, the distinctions are not as clear when analyzing mice congenitally deficient in NK cells. Beige mice which lack NK effector cells and IL-2-inducible NK cells also lack the ability to generate LAK cells. The relationships and differences between NK- and LAK-cell precursors and effectors are discussed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041367334

Download citation: RISBibTeXText

PMID: 3489533

DOI: 10.1016/0008-8749(86)90054-7


Related references

Mechanism of interferon gamma-induced protection of human gliosarcoma cells from lymphokine-activated killer lysis: division of lymphokine-activated killer cells into natural killer- and T-like cells. Neurosurgery 31(3): 534-540, 1992

Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells. Cellular Immunology 118(2): 448-457, 1989

Lysis of fresh murine mammary tumor cells by syngeneic natural killer cells and lymphokine-activated killer cells. Cancer Immunology ImmunoTherapy 25(3): 161-168, 1987

Effect of electric foot shock and psychological stress on activities of murine splenic natural killer and lymphokine-activated killer cells, cytotoxic T lymphocytes, natural killer receptors and mRNA transcripts for granzymes and perforin. Stress 8(2): 107-116, 2005

Comparison of murine lymphokine-activated killer cells, natural killer cells, and cytotoxic T lymphocytes. Cellular Immunology 95(1): 95, 1985

A functional and phenotypic comparison of murine natural killer (NK) cells and lymphokine-activated killer (LAK) cells. International Journal of Cancer 43(5): 940-948, 1989

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2. Cancer Research 44(5): 1946-1953, 1984

Differential radiosensitivity of lymphokine activated killer and natural killer like cells cells suppressing hematopoiesis are identical to natural killer like cells in their radioresistance. Natural Immunity & Cell Growth Regulation 4(5): 255, 1985

Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen. Journal of Immunology 151(12): 6783-6793, 1993

Lymphokine activated killer cells their relationship to natural killer cells anomalous killer cells and cytotoxic t lymphocytes. Federation Proceedings 46(4): 1220, 1987

Functional studies on lymphokine activated killer cells against natural killer sensitive and natural killer resistant targets. Proceedings of the American Association for Cancer Research Annual Meeting 27: 352, 1986

Natural killer (NK) cell subsets in the mouse. NK-1.1+/LGL-1+ cells restricted to lysing NK targets, whereas NK-1.1+/LGL-1- cells generate lymphokine-activated killer cells. Journal of Immunology 145(2): 751-759, 1990

Lymphokine activated killer cells in mouse bone marrow chimeras the relationship to natural killer cells and to alloreactive cytotoxic t cells. Scandinavian Journal of Immunology 22(5): 479-488, 1985

Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication. British Journal of Cancer 67(5): 933-938, 1993

Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells. Journal of Immunology 137(8): 2716-2720, 1986